According to a new report Global Artificial Intelligence in Diagnostics Market, published by KBV research, The Global Artificial Intelligence in Diagnostics Market size is expected to reach $1.3 billion by 2026, rising at a market growth of 27.4% CAGR during the forecast period.

In terms of market share, software emerged as the leading market segment. This high share is due to the growth of AI-based diagnostic software in healthcare. The demand for AI-powered and cloud-based enhanced diagnostic solutions that help improve diagnostic precision when interpreting a patient's medical image is one of the main factors driving the segment.

Neurology had a dominant market share, while radiology is expected to be the fastest-growing segment in the forecast period due to the production of AI-based applications used for diagnostic imaging. Neurology accounts for the highest number of regulatory approvals of the overall AI-based medical diagnostics network. AI diagnostics include early detection and correct diagnosis of numerous neurological disorders, including autism, Alzheimer's disease, Parkinson's disease, ischaemic stroke, and multiple sclerosis.

North America led the industry. This is due to the increasing acceptance of healthcare IT solutions in the field of medical diagnosis, the emergence of a well-established healthcare sector, and high funding for the production of AI-based diagnostic software. The U.S. is leading the market for artificial intelligence in diagnostics in North America. However, Asia Pacific is projected to be the most lucrative market to expand at a significant growth rate during the forecast period. A growing number of policy initiatives to promote healthcare providers and other healthcare organizations to implement AI-based diagnostic technologies and increasing investment by non-profit organizations and private companies to enhance the sharing of knowledge on better clinical results and cost savings are some of the main factors expected to drive the growth of the AI market on a daily basis.

Structural Insights: https://www.kbvresearch.com/artificial-intelligence-diagnostics-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of General Electric (GE) Co. (GE Healthcare), Siemens AG (Siemens Healthineers), Aidoc Medical Ltd., AliveCor, Inc., Imagen Technologies, Inc., VUNO, Inc., IDx Technologies, Inc., NovaSignal Corporation, Riverain Technologies, LLC, and Zebra Medical Vision Ltd.

Global Artificial Intelligence in Diagnostics Market Segmentation

By Diagnosis Type
• Radiology
• Oncology
• Neurology
• Cardiology
• Chest & Lungs
• Pathology and
• Other Diagnosis Types

By Component
• Services
• Software and
• Hardware

By Geography

North America
• US
• Canada
• Mexico
• Rest of North America

Europe
• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

LAMEA
• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Companies Profiled
• General Electric (GE) Co. (GE Healthcare)
• Siemens AG (Siemens Healthineers)
• Aidoc Medical Ltd.
• AliveCor, Inc.
• Imagen Technologies, Inc.
• VUNO, Inc.
• IDx Technologies, Inc.
• NovaSignal Corporation
• Riverain Technologies, LLC
• Zebra Medical Vision Ltd.